Self-assembly and liver targeting of sulfated chitosan nanoparticles functionalized with glycyrrhetinic acid

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 6, 2012, Pages 870-879

  Tian, Qin ^a   Wang, Xiu Hua ^a   Wang, Wei ^a   Zhang, Chuang Nian ^a   Wang, Ping ^a   Yuan, Zhi ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

Drug delivery; Glycyrrhetinic acid; Liver targeting; Polymeric micelles; Sulfated chitosan

Indexed keywords

BASIC SCIENCE; DOXORUBICIN; DRUG CARRIER; FUNCTIONALIZED; HEPG2 CELLS; HYDROPHOBIC GROUPS; IN-VIVO; LIVER CANCER CELLS; LIVER CELLS; LIVER TARGETING; LONG-TERM EFFECTS; POLYMERIC MICELLE; SULFATED CHITOSAN;

CELL CULTURE; CELLS; CHITOSAN; DISEASES; DRUG DELIVERY; NANOPARTICLES; SELF ASSEMBLY;

MICELLES;

CHITOSAN; DOXORUBICIN; DRUG CARRIER; GLYCYRRHETINIC ACID; NANOCARRIER; NANOPARTICLE; STEARIC ACID; SULFATED CHITOSAN; SULFUR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CANCER CELL; CELL STRAIN HEPG2; CHEMICAL MODIFICATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG RELEASE; DRUG TARGETING; DRUG UPTAKE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HYDRODYNAMICS; HYDROPHOBICITY; IC 50; LIGHT SCATTERING; LIVER CANCER; MICELLE; MOUSE; NANOENCAPSULATION; NONHUMAN; SULFATION; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANIMALS; CHITOSAN; CRYSTALLIZATION; DOXORUBICIN; GLYCYRRHETINIC ACID; HEP G2 CELLS; HUMANS; LIVER; MICE; NANOCAPSULES; SULFATES;

EID: 84864109937     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.11.002     Document Type: Article

References (46)

1. Torchilin V.P. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 2007, 24:1-16.
2. L-amino acid) micelles for drug delivery. Adv Drug Deliv Rev 2002, 54:169-190.
3. Moghimi S.M., Hunter A.C., Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001, 53:283-318.
4. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000, 65:271-284.
5. Maeda H., Bharate G.Y., Daruwalla J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm 2009, 71:409-419.
6. Arimura H., Ohya Y., Ouchi T. Formation of core-shell type biodegradable polymeric micelles from amphiphilic poly(aspartic acid)-block-polylactide diblock copolymer. Biomacromolecules 2005, 6:720-725.
7. Yoo H.S., Park T.G. Folate receptor targeted biodegradable polymeric doxorubicin micelles. J Control Release 2004, 96:273-283.
8. Sun H.L., Guo B.N., Cheng R., Meng F.H., Liu H.Y., Zhong Z.Y. Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin. Biomaterials 2009, 30:6358-6366.
9. Kim C., Lee S.C., Kang S.W., Kwon I.C., Kim Y.H., Jeong S.Y. Synthesis and the micellar characteristics of poly(ethylene oxide)-deoxycholic acid conjugates. Langmuir 2000, 16:4792-4797.
10. Despa F., Luo J.T., Li J., Duan Y., Lam K.S. Cholic acid micelles-controlling the size of the aqueous cavity by PEGylation. Phys Chem Chem Phys 2010, 12:1589-1594.
11. Nichifor M., Lopes A., Carpov A., Melo E. Aggregation in water of dextran hydrophobically modified with bile acids. Macromolecules 1999, 32:7078-7085.
12. Choi K.Y., Chung H., Min K.H., Yoon H.Y., Kim K., Park J.K., et al. Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials 2010, 31:106-114.
13. Cho Y.W., Park S.A., Han T.H., Son D.H., Park J.S., Oh S.J., et al. In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: mechanisms, key factors, and their implications. Biomaterials 2007, 28:1236-1247.
14. Kumar M.H.V.R., Muzzarelli R.A.A., Muzzarelli C., Sashiwa H., Domb A.J. Chitosan chemistry and pharmaceutical perspectives. Chem Rev 2004, 104:6017-6084.
15. Son Y.J., Jang J.S., Cho Y.W., Chung H., Park R.W., Kwon I.C., et al. Bioditribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. J Control Release 2003, 91:135-145.
16. Trapani A., Sitterberg J., Bakowsky U., Kissel T. The potential of glycol chitosan nanoparticles as carrier for low water soluble drugs. Int J Pharm 2009, 375:97-106.
17. Wei W., Ma G.H., Wang L.Y., Wu J., Su Z.G. Hollow quaternized chitosan microspheres increase the therapeutic effect of orally administered insulin. Acta Biomater 2010, 6:205-209.
18. Bayat A., Larijani B., Ahmadian S., Junginger H.E., Rafiee-Tehrani M. Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives. Nanomedicine 2008, 4:115-120.
19. Jayakumar R., Prabaharan M., Nair S.V., Tokura S., Tamura H., Selvamurugan N. Novel carboxymethyl derivatives of chitin and chitosan materials and their biomedical application. Prog Mater Sci 2010, 55:675-709.
20. Liu K.H., Chen S.Y., Liu D.M., Liu T.Y. Self-assembled hollow nanocapsule from amphiphatic carboxymethy-hexanoyl chitosan as drug carrier. Macromolecules 2008, 41:6511-6516.
21. Seo D.H., Jeong Y.I., Kim D.G., Jang M.J., Jang M.K., Nah J.W. Methotrexate-incorporated polymeric nanoparticles of methoxy poly(ethylene glycol)-graft chitosan. Colloid Surface B 2009, 69:157-163.
22. Hu F.Q., Meng P., Dai Y.Q., Du Y.Z., You J., Wei X.H., et al. PEGylated chitosan-based polymer micelle as an intracellular delivery carrier for anti-tumor targeting therapy. Eur J Pharm Biopharm 2008, 70:749-757.
23. Hou Z.Q., Han J., Zhan C.M., Zhou C.X., Hu Q., Zhang Q.Q. Synthesis and evaluation of N-succinyl-chitosan nanoparticles toward local hydroxycamptothecin delivery. Carbohyd Polym 2010, 81:765-768.
24. Rekha M.R., Sharma C.P. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption. J Control Release 2009, 135:144-151.
25. Jayakumar R., New N., Tokura S., Tamura H. Sulfated chitin and chitosan as novel biomaterials. Int J Biol Macromol 2007, 40:175-181.
26. Qu G.W., Yao Z., Zhang C., Wu X.L., Ping Q.N. PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: in vitro characterization and in vivo evaluation. Eur J Pharm Sci 2009, 37:98-105.
27. Yao Z., Zhang C., Ping Q.N., Yu L.L. A series of novel chitosan derivatives: synthesis, characterization and micellar solubilization of paclitaxel. Carbohyd Polym 2007, 68:781-792.
28. Fiore C., Eisenhut M., Krausse R., Ragazzi E., Pellati D., Armanini D., et al. Antiviral effect of glycyrrhiza species. Phytother Res 2008, 22:141-148.
29. Asl M.N., Hosseinzadeh H. Review of pharmacological effects of glycyrrhiza sp. and its bioactive compounds. Phytother Res 2008, 22:709-724.
30. Negishi M., Irie A., Nagata N., Ichikawa A. Specific binding of glycyrrhetinic acid to the rat liver membrane. Biochim Biophys Acta 1991, 1066:77-82.
31. Mao S.J., Bi Y.Q., Jin H., Wei D.P., He R., Hou S.X. Preparation, characterization and uptake by primary cultured rat hepatocytes of liposomes surface-modified with glycyrrhetinic acid. Pharmazie 2007, 62:614-619.
32. Tian Q., Zhang C.N., Wang X.H., Huang W., Cha R.T., Wang C.H., et al. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery. Biomaterials 2010, 31:4748-4756.
33. Huang W., Wang W., Wang P., Tian Q., Zhang C.N., Wang C.H., et al. Glycyrrhetinic acid-modified poly(ethylene glycol)-b-poly(γ-benzyl L-glutamate) micelles for liver targeting therapy. Acta Biomater 2010, 6:3927-3935.
34. Terbojevich M., Carraro C., Cosani A. Solution studies of chitosan 6-O-sulfate. Makromol Chem 1989, 190:2847-2855.
35. Tian Q., Wang W., He X.T., Zhu X.C., Huang W., Zhang C.N., et al. Glycyrrhetinic acid-modified nanoparticles for drug delivery: preparation and characterization. Chinese Sci Bull 2009, 54:3121-3126.
36. Yuan X.B., Li H., Yuan Y.B. Preparation of cholesterol-modified chitosan self-aggregated nanoparticles for delivery of drugs to ocular surface. Carbohyd Polym 2006, 65:337-345.
37. Kamiyama K., Onishi H., Machida Y. Biodisposition characteristics of N-succinyl-chitosan and glycol-chitosan in normal and tumor-bearing mice. Biol Pharm Bull 1999, 22:179-186.
38. Janes K.A., Fresneau M.P., Marazuela A., Fabra A., Alonso M.J. Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release 2001, 73:255-267.
39. Lin A.H., Liu Y.M., Huang Y., Sun J.B., Wu Z.F., Zhang X., et al. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery. Int J Pharm 2008, 359:247-253.
40. Tian Q., Wang X.H., Wang W., Zhang C.N., Liu Y., Yuan Z. Insight into glycyrrhetinic acid: the role of the hydroxyl group on liver targeting. Int J Pharm 2010, 400:153-157.
41. Gaumet M., Vargas A., Gurny R., Delie F. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm 2008, 69:1-9.
42. Kim J.O., Kabanov A.V., Bronich T.K. Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicin. J Control Release 2009, 138:197-204.
43. Dilnawaz F., Singh A., Mohanty C., Sahoo S.K. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. Biomaterials 2010, 31:3694-3706.
44. Chiu Y.L., Ho Y.C., Chen Y.M., Peng S.F., Ke C.J., Chen K.J., et al. The characteristics, cellular uptake and intracellular trafficking of nanoparticles made of hydrophobically modified chitosan. J Control Release 2010, 146:152-159.
45. Park E.K., Lee S., Lee Y.M. Preparation and characterization of methoxy poly(ethylene glycol)/poly(e-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials 2005, 26:1053-1061.
46. Banerjee T., Mitra S., Singh A.K., Sharma R.K., Maitra A. Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. Int J Pharm 2002, 243:93-105.